Allowance by the US Patent and Trademark Office of patent application No. 17/391-495 “Oral Rapamycin Nanoparticle Preparations and Use”, exclusively licensed to the Company by Emtora Biosciences .

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Meta Platform’s AI push is a key driver for the company ...